Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Oxford Instruments sees FY in line with market views after 'resilient' performance
(Sharecast News) - Oxford Instruments said on Tuesday that it expects to deliver a "resilient" full-year performance, in line with market expectations. FY26 consensus estimates are for revenue of £420.7m and adjusted operating profit of £71.3m.
In an update for the year to the end of March, the company said full-year order intake is expected to be around 8% higher on an organic constant currency (OCC) basis versus the previous year, with a book-to-bill ratio of approximately 1.07.
Following a "tariff-disrupted" start to the financial year, the company said it has seen continued positive quarter-on-quarter order intake momentum in its Imaging & Analysis division. After a return to growth in the second half, full-year order intake is expected to be in line with the prior year on a reported basis, and marginally up versus the previous year on an OCC basis.
In the Advanced Technologies segment, tailwinds in the compound semiconductor market and increasing traction with volume manufacturing customers, have driven year-on-year order growth of about 30%, it said. Order intake accelerated in the second half, mainly thanks to large US and European commercial customers.
Oxford Instruments said that following receipt of a significant multi-year order this month, the current AT order book "materially covers" planned revenue for FY27, with orders now extending into FY28.
"As anticipated, strong execution and improving market conditions in the second half delivered a group revenue performance significantly ahead of H1, with H2 revenue marginally below the prior year on a reported basis, moving to slightly positive growth on an OCC basis," it said.
Oxford Instruments said group operating profit margin continued to benefit from the cost restructuring actions undertaken at its Belfast imaging business, and from the expected margin improvement from H2 revenue growth.
Chief executive Richard Tyson said: "The group's strong execution in the second half, coupled with excellent order growth in Advanced Technologies, led to a resilient full-year performance against a challenging external backdrop; testament to the great work and agility of all of the team at Oxford Instruments.
"With good momentum and a strong order book we are well positioned for growth into the new financial year and beyond."
Oxford Instruments provides scientific technology tools, software and expertise to academic and commercial partners.
See latest RNS on Investegate
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.